Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning its terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:23:11.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T20:30:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T20:41:10.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is not accessible. The usual study content and navigation are replaced by an error screen and site footer.
    Difference
    17%
    Check dated 2026-09-19T22:10:08.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing Revision: v3.6.5. This is a minor build/update to the site interface and does not affect the trial information or user actions.
    Difference
    0.1%
    Check dated 2026-08-29T20:59:41.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is now displayed on the page, replacing the previous v3.6.4. This indicates a site version update that does not modify the study content or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-08T19:17:22.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.